(Q45015137)

8 December 2017

title

Marked differences in CCR5 expression and activation levels in two South African populations (English)

1 reference

8 December 2017

0 references

4

Caroline T Tiemessen

1 reference

8 December 2017

3

Maria Paximadis

1 reference

8 December 2017

1

Anabela C P Picton

1 reference

8 December 2017

2

Sharon Shalekoff

1 reference

8 December 2017

publication date

1 August 2012

1 reference

8 December 2017

1 reference

8 December 2017

volume

136

1 reference

8 December 2017

issue

4

1 reference

8 December 2017

page(s)

397-407

1 reference

Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

The evolutionary history of the CCR5-Delta32 HIV-resistance mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Novel mutations identified using a comprehensive CCR5-denaturing gradient gel electrophoresis assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Co-receptors for HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency virus type 1 infection and pulmonary tuberculosis: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Optimized lymphocyte isolation methods for analysis of chemokine receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Estrogen regulates CCR gene expression and function in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

T cell chemokine receptor expression in aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Aging Is Associated with Increased Human T Cell CC Chemokine Receptor Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Overview of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Novel APC-like properties of human NK cells directly regulate T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

HIV pathogenesis: knowledge gained after two decades of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2012.03592.X

Natural killer cells in HIV-1 infection: a double-edged sword

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3401978

Duration of sample storage dramatically alters expression of the human immunodeficiency virus coreceptors CXCR4 and CCR5

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3401978

Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry.

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3401978

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3401978

Natural killer cell clones can efficiently process and present protein antigens

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3401978

Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2. ANRS 048 IL-2 Study Group

3 November 2018

1 reference

12 December 2020

CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection

1 reference

12 December 2020

Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection

1 reference

12 December 2020

The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density

1 reference

12 December 2020

The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5

1 reference

12 December 2020

IL-12 as well as IL-2 upregulates CCR5 expression on T cell receptor-triggered human CD4+ and CD8+ T cells

1 reference

12 December 2020

IFN-alpha acts on T-cell receptor-triggered human peripheral leukocytes to up-regulate CCR5 expression on CD4+ and CD8+ T cells

1 reference

12 December 2020

Expression of CCR2, CCR5, and CXCR3 by CD4+ T cells is stable during a 2-year longitudinal study but varies widely between individuals

1 reference

12 December 2020

CCR5 delta32 heterozygosity is associated with an increase in CXCR4 cell surface expression

1 reference

12 December 2020

Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals

1 reference

12 December 2020

10.1111/J.1365-2567.2012.03592.X

Identifiers

DOI

1 reference

8 December 2017

0 references

1 reference